Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01PGJ
|
|||
| Former ID |
DIB001580
|
|||
| Drug Name |
PDM-08
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H15Br2N3O3
|
|||
| Canonical SMILES |
C1C(NC(=O)C1(C[N+]2=CC=CC=C2)N)C(=O)O.Br.[Br-]
|
|||
| InChI |
1S/C11H13N3O3.2BrH/c12-11(7-14-4-2-1-3-5-14)6-8(9(15)16)13-10(11)17;;/h1-5,8H,6-7,12H2,(H-,13,15,16,17);2*1H/t8-,11+;;/m1../s1
|
|||
| InChIKey |
GIZKBHWITTWBAP-IEQXMABBSA-N
|
|||
| CAS Number |
CAS 953074-84-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01380249) PDM08 Clinical Trial in Advanced Solid Tumors. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.